Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics

Peritoneal Dialysis International

Volumn 17, Issue 2, 1997, Pages 136-143

  Hendriks, Pascale M E M ^a   Ho dac Pannekeet, Marja M ^a   Van Gulik, Thomas M ^a   Struijk, Dirk G ^a   Phoa, Saphire S K S ^a   Sie, Leehoey ^a   Kox, Cees ^a   Krediet, Raymond T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Glucose exposure; MTAC creatinine; Peritoneal sclerosis; Peritoneal transport rates; Ultrafiltration

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; ARTICLE; ASCITES; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTESTINE OBSTRUCTION; MALE; PERITONEAL DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SCLEROSIS; SYMPTOM;

EID: 0030690592     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700207     Document Type: Article

References (58)

1. Rottembourg J, Gahl GM, Poignet JL, et al. Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1983; 20:236-42.
2. Junor BJR, Briggs JD, Forwell MA, Dobbie JW, Henderson I. Sclerosing peritonitis - the contribution of chlorhexidine in alcohol. Perit Dial Bull 1985; 5:101-4.
3. Ghandi VC, Humayun HM, Ing TS, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140:1201-3.
4. Bradley JA, McWhinnie DL, Hamilton DNH, et al. Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis. Lancet 1983; ii:113.
5. Hauglustaine D, van Meerbeek J, Monballyu J, Goddeeris P, Lauwerijns J, Michielsen P. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD. Clin Nephrol 1984; 22:158-62.
6. Daugirdas JT, Gandhi VC, McShane AP, et al. Peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients dialysed exclusively with lactate-buffered dialysate. Int J Artif Organs 1986; 9:413-16.
7. Pusateri R, Ross R, Marchall R, Meredith JH, Hamilton RW. Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature. Am J Kidney Dis 1986; 8:56-60.
8. Wilms H, Steinhauer HB, Riede UN, Kirste G. Die sklerosierende peritonitis nach kontinuierlicher ambulanter peritoneal-dialyse (CAPD). Chirurg 1986; 57:737-40.
9. Niaudet P, Berard E, Revillon Y, Lothon M, Broyer M. Sclerosing peritonitis in children. Contr Nephrol 1987; 57:230-8.
10. Korzets A, Korzets Z, Peer G, et al. Sclerosing peritonitis. Possible early diagnosis by computerized tomography of the abdomen. Am J Nephrol 1988; 8:143-6.
11. Holland P. Sclerosing encapsulating peritonitis in chronic ambulatory peritoneal dialysis. Clin Radiol 1990; 41:19-23.
12. Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of Sclerosing encapsulating peritonitis. Arch Surg 1990; 125:1626-8.
13. Ahlmén J, Burian P, Eriksson C, Schön S. Sclerosing encapsulating peritonitis once again. Perit Dial Int 1991; 11:279-82.
14. Greenberg A, Bernardini J, Piraino BM, Johnston JR, Perlmutter JA. Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review. Am J Kidney Dis 1992; 19:252-6.
15. Mutoh S, Machida J, Ueda S, Kitamoto Y, Uemura S. Sclerosing encapsulating peritonitis occurring after very short-term intermittent peritoneal dialysis. Nephron 1992; 62:119-20.
16. Cox SV, Lai J, Suranyi M, Walker N. Sclerosing peritonitis with gross peritoneal calcification: a case report. Am J Kidney Dis 1992; 20:637-42.
17. Assalia A, Schein M, Hashmonai M. Problems in the surgical management of sclerosing encapsulating peritonitis. Isr J Med Sci 1993; 29:686-8.
18. Bhandhari S, Wilkinson A, Sellars L. Sclerosing peritonitis: value of immunosuppression prior to surgery. Nephrol Dial Transplant 1994; 9:436-7.
19. Bowers V, Ackermann JR, Richardson W, Carey LC. Sclerosing peritonitis. Clin Transplantation 1994; 8:369-72.
20. Oulès R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant 1988; 3:66-9.
21. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986; 4:194-203.
22. Rigby RJ. Sclerosing peritonitis: the experience in Australia. Perit Dial Int 1995; 15(Suppl 4):S60.
23. Lee RG. Sclerosing peritonitis. Dig Dis Sci 1989; 43:1473-6.
24. Burstein M, Galun E, Ben-Chetrit E. Idiopathic sclerosing peritonitis in a man. J Clin Gastroenterol 1990; 12:698-701.
25. Wirnsberger GH, Ganser K, Domej W, et al. Sclerosing encapsulating peritonitis: differential diagnosis to peritoneal encapsulation and abdominal cocoon - a case report. Z Gastroenterol 1992; 30:534-7.
26. Masuda C, Fujii Y, Kamiya T, et al. Idiopathic sclerosing peritonitis in a man. Int Med 1993; 32:552-5.
27. Tsunoda T, Mochinaga N, Eto T, Furui J, Tomioka T, Takahara H. Sclerosing encapsulating peritonitis combined with peritoneal encapsulation. Arch Surg 1993; 128:353-5.
28. Slingeneyer A, Canaud B, Mion C. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study. Nephron 1983; 33:133-8.
29. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Arisz L. Peritoneal transport characteristics of water, low-molecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis. Perit Dial Bull 1986; 6:61-5.
30. Struijk DG, Krediet RT, Koomen GCM, et al. Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 1991; 59:213-20.
31. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45:1739-44.
32. Krediet RT, Struijk DG, Boeschoten EW, et al. The time course of peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 13:299-307.
33. Sieck JO, Cowgill R, Larkworthy W. Peritoneal encapsulation and abdominal cocoon. Case reports and a review of the literature. Gastroenterol 1983; 84:1597-602.
34. Hollman AS, McMillan MA, Briggs JD, Junor BJR, Morley P. Ultrasound changes in sclerosing peritonitis following continuous ambulatory dialysis. Clin Radiol 1991; 43:176-9.
35. Krestin Von GP, Kacl G, Hoffmann R, Keusch G, Burger HR. Bildgebende diagnostik der sklerosierenden peritonitis (SP) nach kontinuierlicher ambulanter peritonealdialyse (CAPD). Fortschr Röntgenstr 1992; 157:506-11.
36. Campbell S, Clarke P, Hawley C, et al. Sclerosing peritonitis: identification of diagnostic, clinical and radiological features. Am J Kidney Dis 1994;24:819-25.
37. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
38. Slingeneyer A, Mion C, Mourad G, Canaud B, Faller B, Béraud JJ. Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 1983; 29:633-8.
39. Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory dialysis.Perit Dial Int 1991; 11:166-72.
40. Trudinger BJ, Fitchett DH. Practolol peritonitis presenting as a pelvic mass. Br J Obstet Gynaecol 1976; 83:326-8.
41. Cook ALM, Foy P. Sclerosing peritonitis and practolol therapy. Ann R Coll Surg Engl 1976; 58:473-5.
42. Jackson BT. Surgical treatment of Sclerosing peritonitis caused by practolol. Br J Surg 1977; 64:255-7.
43. Panting AL, Denham HEH. Drug-induced sclerosing peritonitis. N Z Med J 1977; 85:10-12.
44. Smith RC, Gillett DJ, O'Neill JP. Sclerosing peritonitis after practolol administration. Med J Aust 1977; 2:394-8.
45. Thompson RPH, Jackson BT. Sclerosing peritonitis due to practolol. Br Med J 1977; 1:1393-4.
46. Eltringham WK, Espiner HJ, Windsor WO, et al. Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management. Br J Surg 1977; 64:229-35.
47. Chang AR. Test and teach. Number twenty-one. Diagnosis: practolol induced sclerosing peritonitis. Pathology 1980; 12:131-3.
48. Harty RF. Sclerosing peritonitis and propanolol. Arch Intern Med 1978; 138:1424-6.
49. Baxter-Smith DC, Monypenny IJ, Dorricott NJ. Sclerosing peritonitis in patient on timolol. Lancet 1978; ii:149.
50. Clark CV, Terris R. Sclerosing peritonitis associated with metoprolol. Lancet 1983; i:937.
51. Ing TS, Daugirdas JT, Ghandi VC. Peritoneal sclerosis in peritoneal dialysis patients. Am J Nephrol 1984; 4:173-6.
52. Slingeneyer A. Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis. Contr Nephrol 1987; 57:239-47.
53. Dehn TCB, Lucas MG, Wood RFM. Idiopathicsclerosing peritonitis. Postgrad M J 1985; 61:841-2.
54. Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Bull 1984; 4(Suppl 3):S21-8.
55. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Effect of lactate buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1994; 46:282-93.
56. Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41:1280-5.
57. Yamada K, Miyahara Y, Hamaguchi K, et al. Immunohistochemical study of human advanced glycosylation end-products in chronic renal failure. Clin Nephrol 1994; 42:354-61.
58. Junor BJR, McMillan MA. Immunosuppression in sclerosing peritonitis. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications 1993; 9:187-9.